cilofexor: Clinical Trials

3 trials of cilofexor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow cilofexor: new trials by email Literature Review of cilofexor trials Research Report on cilofexor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
Cilofexor - Primary Sclerosing Cholangitis, Compensated Cirrhosis
Phase 1TerminatedGilead Sciences112019-10-172023-07-27
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
Cilofexor - Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC)
Phase 1CompletedGilead Sciences572016-07-132021-01-07
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics
Cilofexor, Placebo - Nonalcoholic Steatohepatitis (NASH)
Phase 1CompletedGilead Sciences1202016-01-202020-10-12

Conditions studied

Cholangitis, Sclerosing (2)  ·  Non-alcoholic Fatty Liver Disease (2)

Sponsors

Gilead Sciences (3)

Countries

United States (3)  ·  New Zealand (1)

Results publications

PMID 38976363